Triethylamine → (2S)-1-(4-Fluoro-benzenesulfonyl)-pyrrolidine-2-carboxylic acid [4-(4-trifluoromethyl-phenyl)-pyrimidin-2-ylmethyl]-amide

HRID 1914530Notes

Reaction equation

HRID 1914530 reaction equation
[F:1][C:2]([F:18])([F:17])[C:3]1[CH:8]=[CH:7][C:6]([C:9]2[CH:14]=[CH:13][N:12]=[C:11]([CH2:15][NH2:16])[N:10]=2)=[CH:5][CH:4]=1.[F:19][C:20]1[CH:25]=[CH:24][C:23]([S:26]([N:29]2[CH2:33][CH2:32][CH2:31][C@H:30]2[C:34](O)=[O:35])(=[O:28])=[O:27])=[CH:22][CH:21]=1.ON1C2C=CC=CC=2N=N1.CCN(CC)CC>CO.CN(C=O)C>[F:18][C:2]([F:1])([F:17])[C:3]1[CH:4]=[CH:5][C:6]([C:9]2[CH:14]=[CH:13][N:12]=[C:11]([CH2:15][NH:16][C:34]([C@@H:30]3[CH2:31][CH2:32][CH2:33][N:29]3[S:26]([C:23]3[CH:24]=[CH:25][C:20]([F:19])=[CH:21][CH:22]=3)(=[O:28])=[O:27])=[O:35])[N:10]=2)=[CH:7][CH:8]=1

Participants

7

Procedure

A mixture of C-[4-(4-trifluoromethyl-phenyl)-pyrimidin-2-yl]-methylamine (92 mg, 0.4 mmol), (S)-1-(4-fluoro-benzenesulfonyl)-pyrrolidine-2-carboxylic acid (99 mg, 0.4 mmol), N-(3-dimethylamniopropyl)-N′-ethylcarbodiimide hydrochloride (139 mg, 0.72 mmol), 1-hydroxybenzotriazole (98 mg, 0.73 mmol), Et3N (0.15 mL, 1.10 mmol), and DMF (2 mL) was stirred at rt for 12 hours. After 12 h, MeOH (0.5 mL) was added to the reaction mixture and resulting solution was purified by preparative reverse-phase HPLC to afford (35 mg, 19%) of a white solid. MS (ESI): mass calcd. for C23H20F4N4O3S, 508.1; m/z found, 509.5 [M+H]+. 1H NMR (500 MHz, CDCl3) δ 8.86 (d, J=5.3, 1H), 8.38 (d, J=8.1, 2H), 8.37-8.33 (m, 1H), 7.99-7.92 (m, 2H), 7.82 (d, J=8.2, 2H), 7.70 (d, J=5.3, 1H), 7.30-7.25 (m, 1H), 4.93-4.76 (m, 2H), 4.31-4.22 (m, 1H), 3.69 (td, J=7.3, 3.7, 1H), 3.25 (td, J=9.8, 6.7, 1H), 2.36-2.29 (m, 1H), 1.97-1.59 (m, 3H).

Workup

  1. waitAfter 12 h
  2. customresulting solution
  3. customwas purified by preparative reverse-phase HPLC

Sources & evidence

ORD record
ord-4d3b4bac2b4f449da5a2342c2e8401d5
Source dataset
uspto-grants-2013_12
Patent number
US08614201B2

Reaction notes

Loading…